Eur Radiol:双相CT检测血栓长度差异能预测急性缺血性卒中的临床预后

2015-10-07 phylis 译 MedSci原创

目的:血栓长度可能高估了早期动脉计算机断层扫描血管造影(CTA)对侧枝循环状态检测的能力。基于双相CT检测的血栓长度的等级系统,研究人员评估血栓长度的差异与临床预后的关系。方法:招募了M1阻断的急性缺血性卒中患者48名。双相CT检测包括非对照增强CT,具有自动跟踪技术的CTA以及造影剂注射40s后进行延迟对照增强CT扫描。在CTA和CECT中血栓长度差异用三点量表进行分级:G0=没有差异,G1=血

目的:基于血栓长度,目前的医生们可能高估了动脉早期的计算机断层扫描血管造影(CTA)对侧支循环状态检测的能力。基于双相CT检测的血栓长度的等级系统,研究人员评估血栓长度的差异与临床预后的关系。

方法:招募了M1阻断的急性缺血性卒中患者48名。双相CT检测包括非对照增强CT,具有自动跟踪技术的CTA以及在造影剂注射40s后进行的延迟对照增强CT扫描(CECT)。在CTA和CECT中血栓长度差异用三点量表进行分级:G0=没有差异,G1=血栓长度无差异,但是远端血栓信号衰减,G2=血栓长度有差异。进行单变量和多变量分析确定3个月不良临床预后的独立预测因子。

结果:血栓差异等级与侧支状态和DSA前向性血流呈显著线性关系,两者具有较好的一致性。在多变量模型中,血栓长度的差异(G2)是不良临床预后的独立预测因子(OR=11.474 (1.350-97.547))。

结论:双相CT检测血栓长度的差异可能是在急性M1阻断患者不良临床预后方面的有用预测因子。

原文出处:

Park M, Kim KE, Shin NY,et al.  Thrombus length discrepancy on dual-phase CT can predict clinical outcome in acute ischemic stroke. Eur Radiol. 2015 Sep 22.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=107761, encodeId=669f10e761b8, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107762, encodeId=243910e7627a, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892686, encodeId=76c3189268610, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Jun 28 07:43:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806037, encodeId=f365180603efb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 06 05:43:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39036, encodeId=e0a2390369e, content=还有这样的方法 又长见识了 以前只知道CTA做血管 原来还有双期扫描 平扫和延迟增强 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Sun Oct 18 00:31:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534698, encodeId=d5cd1534698a1, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Fri Oct 09 12:43:00 CST 2015, time=2015-10-09, status=1, ipAttribution=)]
    2016-08-30 李东泽

    这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=107761, encodeId=669f10e761b8, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107762, encodeId=243910e7627a, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892686, encodeId=76c3189268610, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Jun 28 07:43:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806037, encodeId=f365180603efb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 06 05:43:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39036, encodeId=e0a2390369e, content=还有这样的方法 又长见识了 以前只知道CTA做血管 原来还有双期扫描 平扫和延迟增强 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Sun Oct 18 00:31:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534698, encodeId=d5cd1534698a1, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Fri Oct 09 12:43:00 CST 2015, time=2015-10-09, status=1, ipAttribution=)]
    2016-08-30 李东泽

    这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=107761, encodeId=669f10e761b8, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107762, encodeId=243910e7627a, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892686, encodeId=76c3189268610, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Jun 28 07:43:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806037, encodeId=f365180603efb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 06 05:43:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39036, encodeId=e0a2390369e, content=还有这样的方法 又长见识了 以前只知道CTA做血管 原来还有双期扫描 平扫和延迟增强 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Sun Oct 18 00:31:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534698, encodeId=d5cd1534698a1, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Fri Oct 09 12:43:00 CST 2015, time=2015-10-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=107761, encodeId=669f10e761b8, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107762, encodeId=243910e7627a, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892686, encodeId=76c3189268610, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Jun 28 07:43:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806037, encodeId=f365180603efb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 06 05:43:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39036, encodeId=e0a2390369e, content=还有这样的方法 又长见识了 以前只知道CTA做血管 原来还有双期扫描 平扫和延迟增强 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Sun Oct 18 00:31:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534698, encodeId=d5cd1534698a1, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Fri Oct 09 12:43:00 CST 2015, time=2015-10-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=107761, encodeId=669f10e761b8, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107762, encodeId=243910e7627a, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892686, encodeId=76c3189268610, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Jun 28 07:43:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806037, encodeId=f365180603efb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 06 05:43:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39036, encodeId=e0a2390369e, content=还有这样的方法 又长见识了 以前只知道CTA做血管 原来还有双期扫描 平扫和延迟增强 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Sun Oct 18 00:31:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534698, encodeId=d5cd1534698a1, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Fri Oct 09 12:43:00 CST 2015, time=2015-10-09, status=1, ipAttribution=)]
    2015-10-18 huolongguo2222

    还有这样的方法 又长见识了 以前只知道CTA做血管 原来还有双期扫描 平扫和延迟增强 学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=107761, encodeId=669f10e761b8, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107762, encodeId=243910e7627a, content=这篇咨询不错哦,值得学习,对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Aug 30 23:03:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892686, encodeId=76c3189268610, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Jun 28 07:43:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1806037, encodeId=f365180603efb, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 06 05:43:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=39036, encodeId=e0a2390369e, content=还有这样的方法 又长见识了 以前只知道CTA做血管 原来还有双期扫描 平扫和延迟增强 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Sun Oct 18 00:31:00 CST 2015, time=2015-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534698, encodeId=d5cd1534698a1, content=<a href='/topic/show?id=6be9230842e' target=_blank style='color:#2F92EE;'>#临床预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23084, encryptionId=6be9230842e, topicName=临床预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a72412536387, createdName=budeshao, createdTime=Fri Oct 09 12:43:00 CST 2015, time=2015-10-09, status=1, ipAttribution=)]

相关资讯

NEJM:1例前循环脑进展性梗死报告

患者女性,47岁,既往有偏头痛史,因头部左侧急性头痛发作及左臂轻度乏力入院。 症状发作后5小时行未使用造影剂的脑部计算机断层扫描(CT),右侧大脑中动脉第一节和大脑前动脉第一节示高密度线性区(图A,箭头)。有脑水肿早期信号,包括细微的低衰减,灰白色区分丧失,右侧大脑中动脉和大脑前动脉区域沟消失(图B,箭头)。 4小时后,患者出现昏昏欲睡,左侧完全麻痹。症状发作后9小

Neurology:HIV患者脑动脉重塑对其非栓塞性脑梗死的作用

背景:HIV感染患者易发生脑血管疾病。但是,HIV感染,脑动脉重塑以及卒中之间的关系尚不明确。方法:从284名感染以及非感染HIV的患者大脑中分析大脑动脉(1878部分),得到血管中层厚度,血管壁厚以及腔壁比,确定血管动脉粥样硬化以及脑血管伸展扩张的存在(动脉重塑)。神经病理学评估脑梗死的特征。应用多层模型分析动脉特征与HIV之间的关系。仅在HIV阳性患者中检测动脉特征与脑梗死之间的关系。结果:校

JAMA Neurol:颈内动脉颅内段粥样硬化增高卒中风险

动脉粥样硬化性脑梗死是缺血性卒中最常见的类型。其中,颈内动脉颅内段的粥样硬化被认为是40岁以上人群卒中的最重要危险因素,也是各种卒中防治手段的主要干预靶点。目前,关于白种人中颅内动脉粥样硬化对卒中影响的研究仍较有限。曾有报道发现,当以颈内动脉颅内段的钙化(ICAC)作为动脉粥样硬化的指标,有超过80%的白种人存在颅内动脉粥样硬化。近期,来自于荷兰鹿特丹伊拉姆斯医学中心的M. Arfan Ikram

Stroke:2014 AHA/ASA大脑和小脑梗死后脑水肿的处理声明

流行病学推荐:1.脑梗塞所致严重大脑半球和小脑水肿的术语和定义应该标准化,这会有利于推进多中心和人群为基础的关于该病发病率、流行病学、危险因素和预后的研究。(I;C)2.选择减压颅骨切除术还需要更多的额外数据,包括医生、医院、健康系统或患者的特征差别。(I;C)定义和临床表现的推荐:1.应该采用临床数据辨别梗死和水肿高风险的患者,比如血管闭塞的情况。(I;C)神经影像的推荐:1.预测脑水肿的头CT

急性缺血性卒中:溶栓流程更佳管理

在急性脑梗死的治疗中,唯一可以降低致残率的治疗就是溶栓。大多数学者认为,基于临床和CT选择的缺血性卒中患者,在发病4.5h内可从重组组织型纤溶酶原激活剂(rt-PA)溶栓治疗获益。在2012年国际卒中大会上公布的中国急性缺血性卒中溶栓安全监测研究显示,对中国人群而言,发病3~4.5h溶栓同样有效。为达到治疗获益最大化,应尽可能缩短启动治疗的延误,即在溶栓时间窗内发病的急性脑梗死患者,应尽可能在

Stroke:达比加群疗法治疗无房颤性急性缺血性卒中

急性缺血性卒中患者易早期再发。我们检测了无房颤轻型卒中患者24h内应用达比加群的可行性和安全性。给予轻型卒中无房颤患者(NHISS≤3)达比加群治疗,MRI扫描证实患者急性梗死。药物治疗于梗死24h内开始,持续30天。出现出血症状,治疗停止。招募53名年龄中位数为68岁(四分位间距57-77岁),NHISS评分为1(0-2)患者。基线弥散加权成像体积为0.8(0.3-2.4)mL。无患者症状性出血